Illumina, ArcherDx Expand Partnership on NGS IVD Tests

Jan

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Feb

Featured Webinar

Development of a Novel Multiplex Assay: A Partnership Case Study

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.

Menu

Illumina, ArcherDx Expand Partnership on NGS IVD Tests

To read the full story....

Breaking News

Co-Diagnostics Selling $5M of Shares

Adaptive Biotechnologies Prices Public Offering of Stock

In Brief This Week: Bio-Techne, PerkinElmer, Exosomics, and More

Swedish Diagnostics Firm Elypta Raises €6.1M

Myriad Genetics Seeks Supplemental Approval of HRD Test as CDx for GSK Ovarian Cancer Drug

Sysmex Wins Chinese Approval for Breast Cancer IVD Reagent

Featured White Papers

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

Development of a Novel Multiplex Assay: A Partnership Case Study

What's Popular?

Diagnostics Developers Leap Into Action on Novel Coronavirus Tests

Adaptive Biotechnologies Prices Public Offering of Stock

Quest Diagnostics Acquires Blueprint Genetics

Myriad Genetics Seeks Supplemental Approval of HRD Test as CDx for GSK Ovarian Cancer Drug

Biocartis, AstraZeneca Expand Lung Cancer Biomarker Study With Master Collaboration Agreement

Sponsorships